Healthcare & Pharmaceutical
RSS Feed

Pharma-Bio Serv Announces Closing of Laboratory Assets Sale for $5 Million
9/21/2018 -- 4:45 PM -- Pharma-Bio Serv Inc.

Dynatronics Schedules Conference Call to Report Financial Results for Fourth Quarter and Full Fiscal Year 2018
9/21/2018 -- 4:30 PM -- Dynatronics Corporation

BriaCell to Present Clinical and Scientific Data at International Cancer Immunotherapy and The MicroCap Conferences
9/21/2018 -- 6:30 AM -- BriaCell Therapeutics Corp.

Protege Biomedical Receives FDA Clearance for Bandage to Stop Bleeding
9/20/2018 -- 5:55 PM -- Protege Biomedical, LLC

ENB Therapeutics Closes Series A Round of Funding
9/20/2018 -- 7:30 AM -- ENB Pharma

ProLung, Inc. Announces Addition of Future Board Members
9/19/2018 -- 2:20 PM -- ProLung, Inc.

New Public-Private Partnership Supported by Safe Surgery 2020 and GE Foundation to Transform Surgical Care Across Sub-Saharan Africa
9/19/2018 -- 12:00 PM -- Safe Surgery 2020

Dynatronics to Participate in Ladenburg Thalmann's Healthcare Conference
9/19/2018 -- 9:05 AM -- Dynatronics Corporation

Secarna Pharmaceuticals successfully hosted Inaugural Industry Expert Meeting and Networking Event for the Oligonucleotide Therapeutics Society (OTS) in Munich
9/19/2018 -- 5:50 AM -- Secarna Pharmaceuticals GmbH & Co. KG

Callitas Health, Inc. Announces Corporate Update
9/18/2018 -- 8:30 AM -- Callitas Health, Inc.

Myomo to Present at The MicroCap Conference
9/18/2018 -- 8:00 AM -- Myomo

Dyadic International to Present at The MicroCap Conference on October 2nd in New York City at the Essex House
9/17/2018 -- 4:18 PM -- Dyadic International, Inc.

MorphoSys and LEO Pharma Expand Strategic Alliance to Develop Peptide-derived Therapeutics
9/17/2018 -- 4:15 PM -- MorphoSys AG

Pharnext: David Stout Joins Pharnext's Board of Directors
9/17/2018 -- 12:25 PM -- Pharnext

WNDM Medical Inc. to Host Shareholder and Open Briefing Call
9/17/2018 -- 8:45 AM -- WNDM Medical Inc.

Aytu BioScience Announces Publication of Manuscript Summarizing Results from the Ongoing Natesto(R) Spermatogenesis Study
9/17/2018 -- 8:05 AM -- Aytu BioScience, Inc.

Evotec And Almirall Enter Into Research Collaboration In The Field Of Dermatological Diseases
9/17/2018 -- 1:51 AM -- Evotec AG

Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2018
9/14/2018 -- 4:10 PM -- Pharma-Bio Serv Inc.

ReShape Lifesciences Announces Proposed Public Offering
9/14/2018 -- 4:01 PM -- ReShape Lifesciences Inc.

Sunshine Biopharma Announces $10 Million Equity Financing
9/14/2018 -- 1:15 PM -- Sunshine Biopharma Inc.

MorphoSys and Galapagos Announce Start of a Phase 1 Subcutaneous Bridging Study with MOR106
9/13/2018 -- 4:45 PM -- MorphoSys AG

Intellipharmaceutics Announces One-for-10 Reverse Stock Split
9/13/2018 -- 9:05 AM -- Intellipharmaceutics International Inc.

GT Biopharma Announces Postive Results For Two Next Generation Trikes In Solid Tumors
9/13/2018 -- 8:36 AM -- GT Biopharma, Inc.

DECN Board Of Directors In Final Review Of Preliminary Financing Agreement For $4.75 Million Investment
9/13/2018 -- 8:00 AM -- Decision Diagnostics Corp.

MorphoSys Announces That its Licensee Janssen has Reported That Tremfya(R) Improves Long-Term Patient-Reported Outcomes in Patients with Moderate to Severe Plaque Psoriasis
9/13/2018 -- 4:33 AM -- MorphoSys AG